True Wealth Design’s Coherus Oncology CHRS Stock Holding History

True Wealth Design’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19	Sell	15 -571	-97%	-$781	﹤0.01%	2551
2026 Q2	$821	Buy	586 +246	+72%	+$402	﹤0.01%	2054
2026 Q1	$575	Buy	340 +44	+15%	+$78	﹤0.01%	2001
2025 Q4	$421	Buy	296 +76	+35%	+$111	﹤0.01%	2006
2025 Q3	$361	Sell	220 -566	-72%	-$630	﹤0.01%	2113
2025 Q2	$575	Sell	786 -2,812	-78%	-$2.43K	﹤0.01%	1690
2025 Q1	$2.9K	Sell	3,598 -699	-16%	-$804	﹤0.01%	876
2024 Q4	$5.93K	Buy	4,297 +1,728	+67%	+$1.94K	﹤0.01%	505
2024 Q3	$2.67K	Buy	+2,569	New	+$3.52K	﹤0.01%	708

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's CHRS Position: Q3 2026 in Review

True Wealth Design reduced its Coherus Oncology (CHRS) stake by 97% in Q3 2026, selling an estimated $781 and leaving 15 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

True Wealth Design first reported a position in CHRS in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.93K in Q4 2024. 7 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

True Wealth Design held 15 shares of Coherus Oncology worth $19 as of Q3 2026.
True Wealth Design sold 571 Coherus Oncology shares in Q3 2026, an estimated $781.
Coherus Oncology made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2551 holding.
True Wealth Design first reported a position in Coherus Oncology in Q3 2024 and has held it in 9 quarters since.
True Wealth Design's Coherus Oncology position peaked at $5.93K in Q4 2024.
7 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.